Live feed
Filing
SC 13G
SC 13G0001535610-17-000094·Axsome Therapeutics, Inc.
Schedule 13G ownership disclosure
Axsome Therapeutics Inc
Security class unavailable · CUSIP: 05464T104
Event date: 2017-12-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 704,000
- Percent of class
- 2.7600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-17-000094
- Form type
- SC 13G
- Filer
- Axsome Therapeutics, Inc.
- CIK
- CIK 1579428
- Filed
- Dec 04, 2017
- Reporting period
- Dec 01, 2017
- Description
- Schedule 13G beneficial ownership